All of my Biotech are getting trounced. I am holding my nose on some selling others and adding to a few. EDAP is one of them I am adding to.
Growing revenue. on pace for 35m in revenue. 10m in cash - buying back debt. 10,000 patient study for the number one cancer worldwide SHOWING 85% EFFICACY IN TRIALS. Close to filing for FDA approval on hHIFU Alblatherm and 2012 approval. Even the FDA can't screw up 85% efficacy with no side effects and hospital stays as short as a couple of hours. the rest of the world has approved it. You can drive up to Toronto to the Cleveland Clinic and get treatments now.
This is a winner folks. don't let the sp fool you or the bashers. FDA approval will mean a 7 or 8 bagger from here. GLTA.